9PSafety profile and therapeutic efficacy of one cycle of [177Lu]prostate-specific membrane antigen (PSMA) in end stage metastatic castration-resistant prostate cancer patients with low performance status. (27th February 2019) - Gupta, M; Choudhury, P S; Rawal, S; Goel, H C; Talwar, V; Dutta, K D; Singh, A